PDF] Cell Surface Markers as Therapeutic Targets in Myeloid Leukemia | Semantic Scholar
Catch me if you can: how AML and its niche escape immunotherapy | Leukemia
Leukemia stem cell markers CD123 and CD47 are positively correlated... | Download Scientific Diagram
PDF] Prognostic value of lymphocyte surface markers in acute myeloid leukemia. | Semantic Scholar
JCI Insight - Universal monitoring of minimal residual disease in acute myeloid leukemia
The relationship between the surface markers and FAB subtypes in AML | Download Table
Surface marker expression of AML cells allows definition of two... | Download Table
The relationship between the surface markers and FAB subtypes in AML | Download Table
Frontiers | One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia
IJMS | Free Full-Text | Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia
Frontiers | Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia
Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia - ScienceDirect
CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia | Stem Cell Research & Therapy | Full Text
Emerging Immunotherapies in Acute Myeloid Leukemia Offer Hope in a Difficult Disease
JCM | Free Full-Text | Location First: Targeting Acute Myeloid Leukemia Within Its Niche